|
Q3 FY2026
As of Aug 31, 2026
|
Q2 FY2026
As of May 31, 2026
|
Q1 FY2026
As of Feb 28, 2026
|
Q4 FY2025
As of Nov 30, 2025
|
Q3 FY2025
As of Aug 31, 2025
|
Q2 FY2025
As of May 31, 2025
|
Q1 FY2025
As of Feb 28, 2025
|
Q4 FY2024
As of Nov 30, 2024
|
Q3 FY2024
As of Aug 31, 2024
|
Q2 FY2024
As of May 31, 2024
|
Q1 FY2024
As of Feb 29, 2024
|
Q4 FY2023
As of Nov 30, 2023
|
Q3 FY2023
As of Aug 31, 2023
|
Q2 FY2023
As of May 31, 2023
|
Q1 FY2023
As of Feb 28, 2023
|
Q4 FY2022
As of Nov 30, 2022
|
Q3 FY2022
As of Aug 31, 2022
|
Q2 FY2022
As of May 31, 2022
|
Q1 FY2022
As of Feb 28, 2022
|
Q4 FY2021
As of Nov 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||||||||||||||
| Term deposits | ||||||||||||||||||||
| Notes receivable (Note 4) | ||||||||||||||||||||
| Other assets (Note 6) | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Investment in Donlin Gold (Note 5) | ||||||||||||||||||||
| Assets | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accrued payroll and related benefits | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Other liabilities (Note 8) | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Promissory note (Note 7) | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Common shares | ||||||||||||||||||||
| Contributed surplus | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Equity, Attributable to Parent | ||||||||||||||||||||
| Liabilities and Equity |
Loading...
